retatrutide phase 2 nejm 2023 obesity trial jastreboff π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No weight loss plateau β curve still descending Phase 2 Trial of Retatrutide
Description
it includes the financial exploitation of individuals seeking genuine help for a serious health condition like obesity

Why does this matter on Retatrutide specifically

Adding 1mL of water creates a 10mg/mL solution
Thats how they work to help you lose weight
